Abstract
Nanoparticles mediated vaccine delivery is an emerging technology and considered as better adjuvant for delivering vaccines when compared to conventional delivery system. The purpose of this delivery system is to provide simple stable formulation that elicits lifelong immunity preferably with single shot. In line to develop the biodegradable polymer vaccine delivery system it is necessary to understand about the nature of polymer, type of antigen to be encapsulated, broad idea about immunological sketch. In this review, we attempt to provide an overview about the nano particle vaccine delivery system and interaction between nano particle and the immune system.
Keywords: Biodegradable polymers, immunological profile, nanoparticle, vaccine delivery.
Current Pharmaceutical Biotechnology
Title:Nanoparticles for Triggering and Regulation of Immune Response of Vaccines: Perspective and Prospective
Volume: 14 Issue: 15
Author(s): Sivakumar S. Moni, Mohammed M. Safhi and Bhakti B. Barik
Affiliation:
Keywords: Biodegradable polymers, immunological profile, nanoparticle, vaccine delivery.
Abstract: Nanoparticles mediated vaccine delivery is an emerging technology and considered as better adjuvant for delivering vaccines when compared to conventional delivery system. The purpose of this delivery system is to provide simple stable formulation that elicits lifelong immunity preferably with single shot. In line to develop the biodegradable polymer vaccine delivery system it is necessary to understand about the nature of polymer, type of antigen to be encapsulated, broad idea about immunological sketch. In this review, we attempt to provide an overview about the nano particle vaccine delivery system and interaction between nano particle and the immune system.
Export Options
About this article
Cite this article as:
Moni S. Sivakumar, Safhi M. Mohammed and Barik B. Bhakti, Nanoparticles for Triggering and Regulation of Immune Response of Vaccines: Perspective and Prospective, Current Pharmaceutical Biotechnology 2013; 14 (15) . https://dx.doi.org/10.2174/1389201015666140317120843
DOI https://dx.doi.org/10.2174/1389201015666140317120843 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cholestasis During Pregnancy: Aetiopathogenesis, Foetal-Maternal Repercussions and Pharmacological Treatments
Current Women`s Health Reviews Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416
Current Vascular Pharmacology TRPV4 Agonists and Antagonists
Current Topics in Medicinal Chemistry An Updated Patent Therapeutic Agents Targeting MMPs
Recent Patents on Anti-Cancer Drug Discovery Medical Complications in Anorexia and Bulimia Nervosa
Endocrine, Metabolic & Immune Disorders - Drug Targets Torasemide for the Treatment of Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets The Association of Folic Acid Deficiency and Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Anemia and Chronic Kidney Disease: Making Sense of the Recent Trials
Reviews on Recent Clinical Trials Non-Vitamin K Oral Anticoagulant Drugs for Stroke Prevention in Patients with Atrial Fibrillation and Chronic Kidney Disease
Current Medicinal Chemistry Exogenous Surfactant in Paediatric Acute Lung Injury and Acute Respiratory Distress Syndrome
Current Drug Safety Recent Advances in Antiarrhythmic Drug Treatment of Atrial Fibrillation
Recent Patents on Cardiovascular Drug Discovery Chymase Inhibitors
Current Pharmaceutical Design Chronic Obstructive Pulmonary Disease and Asthma and the Risk of Mild Cognitive Impairment and Dementia: A Population Based CAIDE Study
Current Alzheimer Research Antitumoral-Lipid-Based Nanoparticles: a Platform for Future Application in Osteosarcoma therapy
Current Pharmaceutical Design Topical Delivery of Antioxidants
Current Drug Delivery Promiscuous Biological Features of Newly Emerged SARS-CoV-2 Facilitate its Unrestrained Outbreak: An Update
Coronaviruses Acute Cardioembolic Cerebral Infarction: Answers to Clinical Questions
Current Cardiology Reviews The Need for Physiologically Relevant Peroxisome Proliferator-Activated Receptor-gamma (PPAR-γ) Ligands
Endocrine, Metabolic & Immune Disorders - Drug Targets Genetics and Genomics of Hepatic Acute Phase Reactants: A Mini-Review
Inflammation & Allergy - Drug Targets (Discontinued) The Role of VE-cadherin in Blood-brain Barrier Integrity Under Central Nervous System Pathological Conditions
Current Neuropharmacology